(19)
(11) EP 2 519 645 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.12.2018 Bulletin 2018/52

(45) Mention of the grant of the patent:
22.08.2018 Bulletin 2018/34

(21) Application number: 10798825.5

(22) Date of filing: 29.12.2010
(51) International Patent Classification (IPC): 
C12Q 1/14(2006.01)
(86) International application number:
PCT/EP2010/070883
(87) International publication number:
WO 2011/080305 (07.07.2011 Gazette 2011/27)

(54)

A culture medium for screening or enrichment of methicillin-resistant S. aureus

Nährmedium zum Screenen oder zur Anreicherung von methicillinresistentem S. aureus

Support de culture pour le criblage ou l'enrichissement de S.aureus résistant à la méthicilline

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 31.12.2009 US 291457 P
31.12.2009 EP 09306356

(43) Date of publication of application:
07.11.2012 Bulletin 2012/45

(73) Proprietor: Bio-Rad Europe GmbH
4051 Basel (CH)

(72) Inventors:
  • FAVIER, Christine
    F-92430 Marnes La Coquette (FR)
  • KAMMOUN, Agnès
    F-75002Paris (FR)

(74) Representative: Chajmowicz, Marion et al
Becker & Associés 25, rue Louis Le Grand
75002 Paris
75002 Paris (FR)


(56) References cited: : 
WO-A1-2004/027086
 WO-A1-2004/063391
   
  • WERTHEIM H ET AL: "Improved detection of methicillin-resistant Staphylococcus aureus using phenyl mannitol broth containing aztreonam and ceftizoxime", JOURNAL OF CLINICAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US LNKD- DOI:10.1128/JCM.39.7.2660-2662.2001, vol. 39, no. 7, 1 July 2001 (2001-07-01), pages 2660-2662, XP002281097, ISSN: 0095-1137
  • FELTEN A ET AL: "Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test", JOURNAL OF CLINICAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US LNKD- DOI:10.1128/JCM.40.8.2766-2771.2002, vol. 40, no. 8, 1 August 2002 (2002-08-01) , pages 2766-2771, XP002281096, ISSN: 0095-1137
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).